you are here:

Advanced Enzyme Technologies Ltd.

BSE: 540025 | NSE: ADVENZYMES |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE837H01020 | SECTOR: Pharmaceuticals

BSE Live

Jul 27, 16:00
403.20 -4.90 (-1.20%)
Volume
AVERAGE VOLUME
5-Day
23,412
10-Day
37,399
30-Day
135,202
11,899
  • Prev. Close

    408.10

  • Open Price

    410.85

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    0.00 (0)

NSE Live

Jul 27, 15:58
403.25 -4.95 (-1.21%)
Volume
AVERAGE VOLUME
5-Day
200,166
10-Day
345,186
30-Day
511,392
150,029
  • Prev. Close

    408.20

  • Open Price

    409.40

  • Bid Price (Qty.)

    403.25 (1334)

  • Offer Price (Qty.)

    0.00 (0)

Financials

2020 2019 2018 2017 2016
Cash Flow of Advanced Enzyme Technologies (in Rs. Cr.) Mar 16 Mar 15 Mar 14 Mar 13 Mar 12  
  12 mths 12 mths 12 mths 12 mths 12 mths  
Net Profit/Loss Before Extraordinary Items And Tax 26.03 22.77 11.74 30.85 24.73  
Net CashFlow From Operating Activities 31.50 33.11 17.68 17.98 25.12  
Net Cash Used In Investing Activities -35.70 -6.68 -6.69 -27.90 -39.53  
Net Cash Used From Financing Activities 4.87 -27.05 -11.15 8.26 7.90  
Foreign Exchange Gains / Losses 0.00 0.00 0.00 0.00 0.00  
Adjustments On Amalgamation Merger Demerger Others 0.00 0.00 0.00 0.00 0.00  
Net Inc/Dec In Cash And Cash Equivalents 0.66 -0.62 -0.15 -1.65 -6.51  
Cash And Cash Equivalents Begin of Year 0.87 1.49 1.65 3.30 9.81  
Cash And Cash Equivalents End Of Year 1.53 0.87 1.49 1.65 3.30  
Source : Dion Global Solutions Limited